脱颗粒
免疫学
免疫系统
过敏性炎症
过敏反应
磷酸酶
医学
化学
免疫球蛋白E
过敏
受体
酶
生物化学
内科学
抗体
作者
Peihua Lin,Mengda Cao,Fan Xia,Hongwei Liao,Heng Sun,Qiyue Wang,Ji‐Young Lee,Yan Zhou,Yunan Guan,Cheng Zhang,Zhi‐Qiang Xu,Fangyuan Li,Ji‐Fu Wei,Daishun Ling
标识
DOI:10.1002/advs.202004115
摘要
Abstract Allergic diseases are pathological immune responses with significant morbidity, which are closely associated with allergic mediators as released by allergen‐stimulated mast cells (MCs). Prophylactic stabilization of MCs is regarded as a practical approach to prevent allergic diseases. However, most of the existing small molecular MC stabilizers exhibit a narrow therapeutic time window, failing to provide long‐term prevention of allergic diseases. Herein, ceria nanoparticle (CeNP‐) based phosphatase‐mimetic nano‐stabilizers (PMNSs) with a long‐term therapeutic time window are developed for allergic disease prevention. By virtue of the regenerable catalytic hotspots of oxygen vacancies on the surface of CeNPs, PMNSs exhibit sustainable phosphatase‐mimetic activity to dephosphorylate phosphoproteins in allergen‐stimulated MCs. Consequently, PMNSs constantly modulate intracellular phospho‐signaling cascades of MCs to inhibit the degranulation of allergic mediators, which prevents the initiation of allergic mediator‐associated pathological responses, eventually providing protection against allergic diseases with a long‐term therapeutic time window.
科研通智能强力驱动
Strongly Powered by AbleSci AI